We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Urology

Expert Opinion / Interview · July 12, 2013

Perspectives on Nocturia

Written by
Alan J. Wein MD, PhD(hon), FACS

 

Additional Info

  1. van Kerrebroeck P, Abrams P, Chaikin D, et al. The Standardisation of Terminology in Nocturia: Report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):179-183.

  2. Weatherall M. The risk of hyponatremia in older adults using desmopressin for nocturia: a systematic review and meta-analysis. Neurourol Urodyn. 2004;23(4):302-305.

  3. Yamaguchi O, Nishizawa O, Juul KV, Nørgaard JP. Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial. BJU Int. 2013;111(3):474-484.

  4. Juul KV, Klein BK, Sandstrom R, et al. Gender difference in antidiuretic response to desmopressin. Am J Physiol Renal Physiol. 2011;300(5):F1116-F1122.

Disclosure statements are available on the authors' profiles:

Further Reading